Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204227
Company: SANDOZ

Products on ANDA 204227

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
GATIFLOXACIN	GATIFLOXACIN	0.5%	SOLUTION/DROPS;OPHTHALMIC	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204227

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/11/2016	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204227Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/23/2019	SUPPL-1	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 204227

GATIFLOXACIN

SOLUTION/DROPS;OPHTHALMIC; 0.5%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GATIFLOXACIN	GATIFLOXACIN	0.5%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	202653	LUPIN LTD
GATIFLOXACIN	GATIFLOXACIN	0.5%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	204227	SANDOZ
ZYMAXID	GATIFLOXACIN	0.5%	SOLUTION/DROPS;OPHTHALMIC	Prescription	Yes	AT	022548	ABBVIE